Skip to main content

Establishment profile

Novartis Pharmaceuticals Corporation

59 Route 10, EAST HANOVER, NJ, 07936
325412Pharmaceutical Preparation Manufacturing
EIN 221857084

Download as PDF →

OSHA inspections
0
Violations
0
Penalties
$0
Context
No OSHA inspections on record. This does not mean the employer is violation-free — OSHA inspects a small fraction of workplaces annually.

Summary

Novartis Pharmaceuticals Corporation has no OSHA inspection history on file. Federal records covering wage, environmental, labor relations, and other agencies are noted below where present.

The most recent federal enforcement activity was recorded 0 days ago.

Federal records were found in 1 of 16 sources. Sources without matching records returned empty for this establishment.

Agency coverage

Novartis Pharmaceuticals Corporation appears in EPA environmental compliance, OFLC visa and labor certification, FMCSA motor carrier registration, and UVA Corporate Prosecution Registry records only. No matching records were found in OSHA workplace safety, WHD wage enforcement, MSHA mine safety, NLRB labor relations, SAM.gov federal debarment, CMS nursing home enforcement, CPSC product recalls, or NHTSA vehicle recalls.

OSHA workplace safety

No OSHA inspections, citations, or accidents on file for Novartis Pharmaceuticals Corporation. Verify directly with Occupational Safety and Health Administration

Safety self-report (OSHA 300A)

Recordable injury rates the employer filed with OSHA’s Injury Tracking Application. DART covers cases with days away, restricted, or transferred; TRIR is the total recordable case rate.

DART rate
0.1
vs industry
−0.8
TRIR
0.1
vs industry
−1.3

Reported for 3,621 average annual employees at this establishment.

Source: OSHA ITA Form 300A (employer self-reported). Rates are per 100 full-time equivalent workers. Establishments below the ~10-FTE threshold are not required to report.

Industry benchmark

Industry avg TRIR
1.4
BLS SOII 2024
Industry avg DART
0.9
BLS SOII 2024
Self-reported TRIR
0.1
OSHA ITA Form 300A (employer self-reported)

BLS rates reflect industry-wide averages. Self-reported figures come from OSHA’s Injury Tracking Application; absence of self-reported data does not necessarily indicate non-compliance — many establishments fall below the ITA reporting threshold.

OSHA severe injury reports

Self-reported events under 29 CFR 1904.39 (24-hour notification of hospitalization, amputation, or loss of an eye) · Aug 2015 – May 2025 · 1 in last 5 years

Reports
2
Hospitalizations
2
Amputations
0
Eye losses
0

Most frequent event: Fall on same level due to slip or trip

Source: OSHA Severe Injury Reports (federal OSHA only; state-plan states like California, Oregon, and Washington maintain their own programs and do not consistently report into this feed).

Severe injury reports — events

Each row is a hospitalization, amputation, or eye-loss event the employer self-reported to OSHA under 29 CFR 1904.39. Narratives are written by the reporting employer.

DateEventBody partOutcome
May 31, 2025Fall on same level due to slip or tripAnkle(s)Hospitalized
Aug 26, 2015Other animal bites, nonvenomousNonclassifiableHospitalized

Source: OSHA Severe Injury Reports. Federal-OSHA jurisdiction only by default; some state-plan programs report voluntarily.

Activity timeline

Data refreshed
Weekly
First OSHA inspection
Most recent activity
0 days ago

Most recent federal enforcement activity recorded 0 days ago. Data on this page is refreshed weekly.

Wage & Hour Division (WHD)

No WHD wage, overtime, or child-labor enforcement cases on file for Novartis Pharmaceuticals Corporation. Verify directly with Wage and Hour Division

Mine safety (MSHA)

No MSHA mine safety violations on file for Novartis Pharmaceuticals Corporation. Verify directly with Mine Safety and Health Administration

Labor relations (NLRB)

No NLRB unfair labor practice charges or union representation cases on file for Novartis Pharmaceuticals Corporation. Verify directly with National Labor Relations Board

Visa & labor certification (OFLC)

Total applications
144
Certified
144
Avg wage ratio
1.01x
H-1BE-3 Australian

Office of Foreign Labor Certification — labor condition applications for H-1B, H-2A, H-2B visa programs. Wage ratio = offered / prevailing wage.

Environmental compliance (EPA)

EPA inspections
7
Quarters non-compliant
12

EPA Enforcement and Compliance History — Clean Air Act, Clean Water Act, RCRA, Safe Drinking Water Act. Status: Significant Violation.

Motor carrier safety (FMCSA)

DOT number
815169
Operation
A

Federal Motor Carrier Safety Administration — DOT-regulated carrier registration and fleet data.

Federal criminal prosecution record

Prosecutions
1
Total payments
$170.0M
Disposition
Guilty Plea
Crime type
FDCA / Pharma

First case: 2011-01-28. Most recent: 2011-01-28. Source: UVA Corporate Prosecution Registry — federal pleas, DPAs, and NPAs.

In the news

Other employers in this industry and state

Other employers in pharmaceutical preparation manufacturing within NJ, ordered by federal enforcement volume:

Related searches

Need API access, bulk download, or licensed redistribution? The website is free. Programmatic and licensed access is handled separately.

Contact sales →

About this data

This profile aggregates federal enforcement records on Novartis Pharmaceuticals Corporation from every major federal compliance and enforcement source plus the UVA Corporate Prosecution Registry. OSHA workplace safety inspections, WHD wage cases, MSHA mine safety, EPA environmental enforcement, NLRB labor relations, OFLC visa/labor certification, FMCSA motor carrier registration, SAM.gov debarments, CMS nursing-home records, BLS industry safety benchmarks, OSHA ITA self-reported injury rates, SEC enforcement and financial disclosures, CPSC and NHTSA recalls.

Establishments are matched across agencies using normalized employer name, state, and ZIP code.

OSHA citations typically appear 3–8 months after the inspection, so very recent enforcement actions may not yet be reflected. Profiles may be incomplete if the establishment operates under multiple legal names or files under variations our entity-matching rules don’t yet cover. To report a missing record or correction, email corrections@fastdol.com.

Frequently asked

What is Novartis Pharmaceuticals Corporation's OSHA violation history?
Novartis Pharmaceuticals Corporation has no OSHA inspections on record.
How does Novartis Pharmaceuticals Corporation's safety record compare to its industry?
Novartis Pharmaceuticals Corporation operates in the pharmaceutical preparation manufacturing industry. The industry average Total Recordable Incident Rate (TRIR) is 1.4. Novartis Pharmaceuticals Corporation's self-reported DART rate is 0.06 compared to an industry average of 0.9.